Clinical Trials at UPMC Hillman Cancer Center

As of June 2026, 91 paid clinical trials are recruiting at UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 8, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

91 clinical trials at UPMC Hillman Cancer Center

·Clear filters·↓ Download CSV

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

for Melanoma

1 location in Pittsburgh

Sponsor: Yana Najjar

Sex: All·Age: 18+

Code: NCT04658303·Recruiting

Apply to this trial

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for Retroperitoneal Sarcoma

109 locations incl. Birmingham

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All·Age: 18+

Code: NCT04031677·Phase 3·Recruiting

Apply to this trial

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

for Melanoma

1 location in Pittsburgh

Sponsor: Dan Zandberg

Sex: All·Age: 18+

Code: NCT04114136·Phase 2·Recruiting

Apply to this trial

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

for Chronic Graft Versus Host Disease

9 locations incl. Gainesville

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT04431479·Recruiting

Apply to this trial

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma

15 locations incl. La Jolla

Sponsor: Bicara Therapeutics

Sex: All·Age: 18+

Code: NCT04429542·Phase 1·Recruiting

Apply to this trial

Converting HR+ Breast Cancer Into an Individualized Vaccine

for Breast Cancer

8 locations incl. Los Angeles

Sponsor: Weill Medical College of Cornell University

Sex: Female·Age: 18 - 90

Code: NCT03804944·Phase 2·Recruiting

Apply to this trial

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

for Gastric Cancer

Drug: Cabozantinib

2 locations incl. Westwood

Sponsor: Anwaar Saeed

Sex: All·Age: 18+

Code: NCT03539822·Phase 1, Phase 2·Recruiting

Apply to this trial

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for Solid Tumors

65 locations incl. Tucson

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT03486873·Phase 3·Recruiting

Apply to this trial

Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

for Leukemia, Lymphocytic, Chronic, B-Cell

84 locations incl. Birmingham

Sponsor: Juno Therapeutics, a Subsidiary of Celgene

Sex: All·Age: 18+

Code: NCT03331198·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

for Previously Untreated Relapsed Refractory Acute Myeloid Leukemia

19 locations incl. Phoenix

Sponsor: Beat AML, LLC

Sex: All·Age: 18+

Code: NCT03013998·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer (NSCLC)

1 location in Pittsburgh

Sponsor: Olivera Finn

Sex: All·Age: 18+

Code: NCT01720836·Phase 1, Phase 2·Recruiting

Apply to this trial